[PDF] from dominiopublico.gov.brTL Mitchell - 2011 - books.google.com Cambridge University Press has long been a pioneer in the reissuing of out-of-print titles from its own backlist, producing digital reprints of books that are still sought after by scholars and students but could not be reprinted economically using traditional technology. The Cambridge ... Cited by 103 - Related articles - All 4 versions
L Eric, CJ Yeo, KD Lillemoe, B Biedrzycki… - Annals of …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > February ... Cited by 6 - Related articles - All 8 versions
P Yue, X Zhang, D Paladino, B Sengupta… - Oncogene, 2011 - nature.com We present evidence that the cisplatin-resistant human ovarian cancer lines, A2780S/CP1 (S/CP1), A2780S/CP3 (S/CP3) and A2780S/CP5 (S/CP5), derived by subjecting the sensitive A2780S ovarian cancer line to multiple rounds of cisplatin treatments followed by ...
[PDF] from oxfordjournals.orgAL Potosky, JL Malin, B Kim… - Journal of the …, 2011 - jnci.oxfordjournals.org Myeloid colony-stimulating factors (CSFs) decrease the risk of febrile neutropenia (FN) from high-risk chemotherapy regimens administered to patients at 20% or greater risk of FN, but little is known about their use in clinical practice. We evaluated CSF use in a multiregional ... Cited by 2 - Related articles - All 4 versions
R Paine 3rd, TJ Standiford, RE Dechert… - Critical Care …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > ...